v3.26.3
Balance Sheet Components
 9 Months Ended
Sep. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
As of
September 30, 2026December 31, 2025
Accrued compensation$20,693 $32,179 
Accrued clinical and other research & development costs
16,568 22,283 
Accrued manufacturing costs9,502 5,336 
Operating lease liability, current10,407 9,463 
Finance lease liability, current
105 83 
Deferred research and development funding liability, current16,420 21,101 
Other accrued costs and current liabilities7,863 7,401 
Total accrued expenses and other current liabilities$81,558 $97,846